ABSTRACT
The presence of PER-1- and OXA-10-like beta-lactamases was investigated by PCR in 49 ceftazidime-resistant Pseudomonas aeruginosa isolates from patients hospitalised in the 24-bed general intensive care unit of the Istanbul Faculty of Medicine during a 12-month period between February 1999 and February 2000. The clonal relatedness of the isolates was investigated by random amplified polymorphic DNA (RAPD) analysis, and the sequences of the PER-1 and OXA genes from all isolates were determined. The rates of resistance of the isolates to imipenem, aztreonam and cefepime were 98%, 92% and 96%, respectively, and to piperacillin and piperacillin-tazobactam were 41% and 37%, respectively. Using the double-disk synergy test, 37% (18/49) of the isolates were identified as extended-spectrum beta-lactamase producers. The PER-1 gene was identified in 86% (42/49) and the OXA-10 gene in 55% (27/49) of the ceftazidime-resistant isolates. Of isolates carrying the PER-1 gene, 48% (20/42) also carried the OXA-10 gene. The respective nucleotide sequences were identical for each isolate. Sixteen RAPD patterns were detected among the PER-1-positive isolates, but 60% (25/42) of the PER-1-positive isolates belonged to two distinct patterns, while the remainder exhibited a wide clonal diversity. The results indicated that the prevalence of PER-1- and OXA-10-like beta-lactamases remains high among ceftazidime-resistant P. aeruginosa isolates in Turkey.
Subject(s)
Ceftazidime/pharmacology , Cephalosporin Resistance/physiology , Pseudomonas aeruginosa/drug effects , beta-Lactamases/metabolism , Anti-Bacterial Agents/pharmacology , Humans , Intensive Care Units , Pseudomonas Infections/drug therapy , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/enzymology , TurkeyABSTRACT
Burkholderia stabilis was grown from blood cultures of seven patients presenting with signs and symptoms of septicaemia in the intensive care unit at Mersin University Hospital, Mersin, Turkey between July and October 2002. Four patients had one B. stabilis-positive blood culture, two patients had two, and one patient had four. Isolates from six of seven patients had the same resistotype and random amplified polymorphic DNA analysis type. Despite treatment with ciprofloxacin and imipenem, to which the strains were susceptible, all patients died one to eight days after isolation of B. stabilis from their blood. B. stabilis should be regarded as an opportunistic pathogen that may cause nosocomial bloodstream infections.
Subject(s)
Bacteremia/microbiology , Burkholderia Infections/microbiology , Cross Infection/microbiology , Intensive Care Units , Opportunistic Infections/microbiology , Adolescent , Adult , Aged , Bacteremia/epidemiology , Bacteremia/prevention & control , Bacterial Typing Techniques , Burkholderia/classification , Burkholderia/genetics , Burkholderia Infections/epidemiology , Burkholderia Infections/prevention & control , Ciprofloxacin/therapeutic use , Cross Infection/epidemiology , Cross Infection/prevention & control , Drug Resistance, Bacterial , Drug Therapy, Combination/therapeutic use , Hospital Mortality , Hospitals, University , Humans , Imipenem/therapeutic use , Infection Control , Male , Middle Aged , Opportunistic Infections/epidemiology , Opportunistic Infections/prevention & control , Random Amplified Polymorphic DNA Technique , Retrospective Studies , Risk Factors , Treatment Outcome , Turkey/epidemiologyABSTRACT
The in vitro activities of ciprofloxacin, ofloxacin, norfloxacin, levofloxacin and gemifloxacin against 343 clinical isolates were compared. Gemifloxacin showed the greatest activity, with MIC90 values as low as 0.03-0.25 mg/L against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, methicillin-susceptible Staphylococcus aureus and Klebsiella pneumoniae, while methicillin-resistant Staphylococcus aureus, Enterococcus spp., Pseudomonas spp., Acinetobacter spp., Escherichia coli and Enterobacter spp. strains exhibited low rates of susceptibility to all five fluoroquinolones.
